Axcess News – Lifestyle
Author:
NEKTAR THERAPEUTICS
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 7, 2026
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets
March 6, 2026
Nektar Therapeutics to Participate in Two Investor Conferences in March
March 5, 2026
←
Previous Page
1
2